The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://phoebealqq596991.nico-wiki.com/2001338/retatrutide_vs_tirzepatide_a_comparative_analysis